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A B S T R A C T
Almost a third of Irish children are now overweight and the country ranks 58th out of 200 countries for its
proportion of overweight youths. With the rising obesity epidemic, and the impaired immune responses of this
population, it is vital to understand the effects that obesity has on the immune system and to design future
therapeutics, adjuvants and vaccines with overweight and obese populations in mind. Many current vaccines use
adjuvants that have been found to be less effective at stimulating the immune response in children compared
with adults and there is now substantial effort to design paediatric-focused adjuvants. Additionally, vaccine
responses have been shown to be less effective in obese populations indicating that this is a particularly vul-
nerable population. We have recently identified cytosolic nucleic acids (CNAs), as novel candidate adjuvants for
childhood vaccines. Here we investigated whether immune responses to these candidate adjuvants were ad-
versely affected in infants born to overweight or obese mothers, and in overweight and obese children. Type I
Interferon (IFN) and proinflammatory cytokines such as Tumor Necrosis Factor α (TNFα) are vital for driving
innate and adaptive immune responses. We found that childhood obesity conferred no significant adverse effect
on CNA-induced Type I IFN responses when compared with lean children. Similarly, Type I IFN responses were
intact in the cord blood of babies delivered from overweight and obese mothers, when compared with lean
mothers. There was also no significant impact of obesity on CNA-induced TNFα responses in children or from
cord blood of infants born to overweight/obese mothers. In all cases, there was a tendency towards decreased
production of innate cytokine Type I Interferon and TNFα, however there was no significant negative correla-
tion. Interestingly, high maternal BMI showed weak and moderate positive correlation with IL-12p70 and IFNγ,
respectively, in response to CNA stimulation. This study demonstrates that future adjuvants can be tailored for
these populations through the use of activators of CNA sensors.
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1. Introduction
Obesity has become a global epidemic over a period of only two
decades. It now represents an urgent medical and a major societal
challenge for which the solution certainly requires a multidisciplinary
approach. Obese individuals are at higher risk of a wide range of in-
fections including postoperative infections and other nosocomial in-
fections, and also of developing serious complications resulting from
common infections [1]. Obese individuals have been shown to be at
increased risk of infection from certain vaccine-preventable diseases,
such as tetanus, hepatitis B and influenza, due to poorer responses to
vaccines in these individuals [2–4]. Although there is limited data
concerning the effect of obesity on vaccine efficacy in neonates born to
obese mothers, limited data from overweight and obese children sug-
gest that responses to vaccinations are impaired in these groups [2,5].
Data from obese adults would also suggest that obesity increases the
chances of a poor vaccine-induced immune response [3,4,6,7]. One
study investigating the effect of increased body mass index (BMI) on
vaccination responses showed that overweight children had reduced
tetanus titers following vaccination when compared to lean children
[2]. Another study in adults receiving Hepatitis B vaccination showed
that obese adults have limited protection against the disease compared
to lean adults [3]. Influenza vaccine responses are also affected by
obesity, with increased risk of influenza among vaccinated adults who
are obese [4]. Interestingly, initial antibody production is intact in
obese individuals, however at later sampling, 12months post vaccina-
tion, these antibody titers decreased below healthy weight individuals
[7]. CD4+ and CD8+ T cell responses ex vivo were also decreased in
obesity [7,8]. Obesity in adults is defined as a BMI≥ 30 kg/m [6],
while for children it is more appropriate to use a BMI z-score. BMI z-
scores are measures of relative weight adjusted for child age and sex
[5].
We have recently identified a potential novel adjuvant for childhood
vaccines. In adults, Poly(I:C) or Poly(dA:dT), when transfected in to
cells, activate cytosolic nucleic acid (CNA) sensors and induce Type I
Interferon (IFN) production along with other proinflammatory cyto-
kines such as Tumor Necrosis Factor α (TNFα) [9]. It has previously
been shown that while other activators of the innate immune system
such as Lipopolysaccharide (LPS) and CpG, TLR4 and 9 ligands re-
spectively, function well in adults, they are less able to activate the
immune system of neonates and young children [10–13]. Adding to this
defective paediatric immune response to TLRs, maternal obesity has
been shown to lead to diminished responses to TLR ligands in cord
blood monocytes and dendritic cells, when compared to cord blood of
lean mothers [14], suggesting that adjuvants targeting these pathways
[15–17] would be less efficient in neonates born to obese mothers.
Cytosolic Poly(I:C) and Poly(dA:dT), unlike many Toll Like Receptor
(TLR) agonists, can activate the neonatal immune response as effi-
ciently as in adults, thereby opening up the possibility of harnessing
these responses for broader use in adjuvant development.
In this study, we wished to investigate whether the CNA responses
previously observed in neonates and children were intact in neonates
born to overweight or obese mothers, and in overweight and obese
children.
2. Materials and methods
2.1. Subjects
Umbilical cord blood samples were obtained from term births fol-
lowing normal pregnancy, labour and delivery at National Maternity
Hospital (NMH), Holles St, Dublin 2. All infants had an uncomplicated
postnatal course and Apgar scores of 9 at 5min. Maternal BMI at
booking appointment was recorded. A BMI of 18.5–24.9 was classified
as healthy, BMI between 25 and 29.9 was classified as overweight,
while a BMI of> 30 was classified as obese. Venous blood from infants,
children and adolescents of various ages was collected during elective
surgical procedures, where no indication of infection or underlying
genetic or endocrine disease was present, (such as hydrocele repair,
umbilical hernia repair, onychocryptosis, orchiopexy repair) in Our
Lady’s Children’s Hospital Crumlin (OLCHC), Dublin 12. In all cases
children had an extra 1–10ml of blood drawn post-anaesthetic, thus
avoiding extra venupuncture. Children’s BMI, age and sex at blood
draw was recorded and BMI z-scores were calculated. Volumes drawn
were age and weight dependent, according to standard, approved
guidelines. Ethics approval was obtained from the Ethics Committees of
NMH and OLCHC and informed consent was obtained from each subject
or their parent/guardian. Adult blood samples were from healthy
adults, supplied by the Irish Blood Transfusion Service.
2.2. Isolation of mononuclear cells
Primary PBMCs or CBMCs were isolated from healthy human blood
or cord blood. Cells were cultured at 37 °C, 5% CO2, 95% air in RPMI-
1640, with stable 2.5mM L-glutamine and 0.5 mM sodium pyruvate
with 10% FBS (all from Sigma-Aldrich).
2.3. Stimulation of PBMCs and CBMCs
Poly(I:C) (5 µg/ml) (Invivogen) and Poly(dA:dT) (5 µg/ml) (Sigma-
Aldrich) were transfected into PBMCs or CBMCs using TransIT-X2
(Mirus).
2.4. Measurement of cytokines
HEK Blue TNFα/IFNα/β Assays were performed as per manu-
facturer’s instructions using Quanti-Blue Detection Reagent. SEAP le-
vels were determined using a spectrophotometer plate reader at
630 nm. BioLegend LEGENDplex™ Human Inflammation Panel (13-
plex) was carried out as per manufacturer’s instructions to determine
levels of IFNγ and IL-12p70. A BD LSR Fortessa cell analyser was used
to acquire samples and BioLegend LEGENDplex™ software was used for
analysis.
2.5. Statistical analyses
Data was analysed with GraphPad Prism software. Normality testing
was carried out using Shapiro-Wilk and D’Agostino & Pearson omnibus
normality testing. When datasets were found to follow a non-normal
distribution a Kruskal-Wallis with Dunn’s multiple comparison test or
Mann Whitney U test was carried out for comparison of groups. For
correlation analysis, Pearson correlation coefficient was used when
datasets were found to follow a Gaussian distribution, while datasets
with non-normal distribution were tested for correlation using
Spearman’s rank correlation. Two-tailed tests were used throughout,
and the statistical approaches were all deemed to be valid for each
individual experiment.
3. Results
It is widely accepted that obesity has immune complications, both
co-morbid disease and inflammation, and immune dysregulation, and
can often lead to decreased immune response to infection or vaccina-
tion [18]. It is also well established that the innate immune systems of
children do not always function in the same manner or with the same
efficiency as adults [19,20]. Deficiencies in the responses to TLR acti-
vation in children is an example of how the immune system of children
and adults differs [12,13]. We have recently reported that Poly(I:C) and
Poly(dA:dT), activators of the cytosolic nucleic acid sensors of the in-
nate immune system, can activate the immune systems of neonates and
infants as efficiently as in adults [9]. Given that many of the adjuvants
in current use rely on activating TLR pathways, we hypothesise that
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Poly(I:C) or Poly(dA:dT) may be candidates for future childhood vac-
cines. We were interested in investigating the effect of obesity on the
Poly(I:C) and Poly(dA:dT) responses of neonates and children. We
therefore re-analysed previously studied cord blood data in the context
of BMI, and also added a cohort of overweight or obese children to
previously acquired data on childhood responses to CNA. Character-
istics of our study groups used to investigate the effect of maternal
obesity on neonatal responses are presented in Table 1.
Mimicking viral infection through activation of cytosolic RLRs/
dsDNA sensors with transfected Poly(I:C) and Poly(dA:dT) resulted in
equivalent Type I IFN production in CBMCs regardless of whether
maternal BMI was in the healthy, overweight or obese range (Fig. 1A
and C). Correlation analysis confirmed our grouping analysis, showing
no positive or negative correlation between BMI and Poly(I:C)- or Poly
(dA:dT)-induced Type I IFN responses (Fig. 1B and D). We had pre-
viously published that cytosolic Poly(I:C)-induced Type I IFN levels in
CBMCs were higher than levels induced in adult PBMCs [9]. Here,
stratification of responses by maternal BMI grouping demonstrates that
this boost in immune stimulation is lost with increasing BMI, however
levels of IFN production never drop below adult levels previously
shown (0.842 AU ± 0.092) [9], as illustrated by the dashed lines on
Fig. 1A.
When TNFα was measured in response to Poly(I:C) or Poly(dA:dT)
transfection, in CBMCs from babies delivered from mothers with dif-
ferent BMIs, we again observed no significant difference in cytokine
production between CBMCs from healthy, overweight or obese mothers
when grouped according to BMI (Fig. 2A and C). Similar to Type I IFN
production, levels of TNFα production tend to decrease with increasing
BMI groups, though not significantly and no negative correlation was
found between maternal BMI and levels of CNA-induced TNF following
correlation analysis. Levels of TNFα production in response to CNA also
remain greater than or equal to previously observed adult levels (Poly
(I:C): 33.65 pg/ml ± 0.8.58, Poly(dA:dT): 48.51 pg/ml ± 14.18 (da-
shed lines Fig. 2A and C)) [9], regardless of maternal BMI. Taken to-
gether these results suggest that maternal BMI, while not having a ne-
gative correlation with innate cytokine output, does have the effect of
blunting the cord blood responses to transfected Poly(I:C) or Poly
(dA:dT) thereby eliminating the previously observed enhancement in
Table 1
Characteristics of maternal lean, overweight & obese study group.
Characteristic Lean Overweight Obese
BMI, mean (SD), kg/m2 22.35 (1.82) 27.5 (1.38)*** 32.5 (2.10)***
BMI range 17.84–24.96 25.34–29.75 30–36.64
Maternal Age, mean (SD), years 36.5 (2.87) 34.93 (4.68) 33.66 (4.89)
Neonatal Birthweight, mean (SD),
kg
3.49 (0.57) 3.87 (0.55) 3.76 (0.57)
Fetal Sex, M:F Ratio (n number) 28:21 (47) 14:8 (22) 6:8 (14)












































Fig. 1. Relationship of Type I IFN production in CBMCs to increasing maternal BMI. Neonatal cord blood mononuclear cells (CBMCs) from babies born to healthy,
overweight or obese mothers were stimulated with (A and B) Poly(I:C) or (C and D) Poly(dA:dT) transfection for 24 h. Levels of IFNα/β were assayed via HEK-Blue™
IFNα/β SEAP assay. (A and C) Data are mean ± SEM (n≥ 14 donors in each group). Kruskal-Wallis non-parametric test with Dunn’s post-test was used to compare
groups. (B and D) Correlation analysis of Type I IFN production and maternal BMI was carried out using Spearman’s rank correlation testing. Dashed line represents
adult Type I IFN production following relevant stimulation.
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cytokine production in healthy CBMCs when compared with lean adult
PBMCs [9]. Notably, maternal BMI does not affect the cord blood re-
sponses to transfected Poly(I:C) or Poly(dA:dT) to such a degree that it
inhibits cytokine responses to below that of an adult.
We were also interested in whether obesity in childhood had an
effect on Type I IFN and TNFα responses to transfected Poly(I:C) and
Poly(dA:dT). Characteristics of our study groups used to investigate the
effect of paediatric obesity on cytokine responses are presented in
Table 2.
Interestingly, we found that while there was a slight tendency to-
wards decreased Type I IFN production in overweight/obese children,
there was no significant difference in Type I IFN production between
our healthy and overweight/obese groups in response to either Poly
(I:C) or Poly(dA:dT) transfection (Fig. 3A and B). We also tested the
TNFα responses of healthy or overweight/obese children to Poly(I:C) or
Poly(dA:dT) transfection and found that there was no significant dif-
ference in the levels of TNFα produced regardless of BMI z-scores
(Fig. 3C and D). In all cases, there was no correlation between BMI and
CNA-induced cytokine production.
Type I IFN and TNFα can promote a Th1-type immune response
which is highly desirable in shaping immunity in response to in-
tracellular bacteria. Due to the potential of Poly(I:C) transfection to
induce substantial Type I IFN and TNFα in neonates regardless of ma-
ternal BMI, we sought to explore whether Poly(I:C) could induce IL-
12p70, another important Th1-polarising cytokine, in the cord blood of
babies delivered from overweight/obese mothers. Fig. 4A shows IL-
12p70 production in CBMCs from overweight/obese mothers in re-
sponse to Poly(I:C) compared to CBMCs from healthy weight mothers.
There was no significant difference between the groups but when
analysed for correlation, IL-12p70 production was found to positively
correlate with BMI (Fig. 4B). IFNγ, considered both an innate and



































Poly(dA:dT) r = 0.19
n = 54
Fig. 2. Relationship of TNFα production to maternal BMI in CBMCs activated with cytosolic nucleic acid. Neonatal cord blood mononuclear cells (CBMCs) from
babies born to healthy, overweight or obese mothers were stimulated with (A and B) Poly(I:C) or (C and D) Poly(dA:dT) transfection for 24 h. Levels of TNFα were
assayed via HEK-Blue™ TNFα SEAP assay. (A and B) Data are mean ± SEM (n≥ 14 donors in each group). Kruskal-Wallis non-parametric test with Dunn’s post-test
was used to compare groups. (B and D) Correlation analysis of TNFα production and maternal BMI was carried out using Spearman’s rank correlation testing. Dashed
line represents adult TNFα production following relevant stimulation.
Table 2
Characteristics of lean & overweight/obese paediatric groups.
Characteristic Lean Overweight/Obese P value
BMI z-score, mean (SD) 0.06 (0.67) 2.29 (0.52) < 0.001
Age, mean (SD), years 12.21 (2.99) 13.13 (2.66) 0.35
Fetal Sex, M:F ratio 12:3 10:10 N/A














































































Fig. 3. Cytosolic nucleic acid-induced Type I IFN and TNFα production remain intact in overweight and obese children. PBMCs from healthy, overweight or obese
children were stimulated with (A and C) Poly(I:C) or (B and D) Poly(dA:dT) transfection 24 h. Levels of IFNα/β or TNFα were assayed via HEKBlue™ IFNα/β SEAP or
HEK-Blue™ TNFα SEAP assay. (Right panels) Data are mean ± SEM (n≥ 15 donors in each group). Kruskal-Wallis non-parametric test with Dunn’s post-test was
used to compare groups. (Left panels) Correlation analysis of Type I IFN or TNFα production and maternal BMI was carried out using Spearman’s rank correlation
testing.
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predominantly produced by CD4+ Th1 and CD8+ cytotoxic T cells,
driving further differentiation of T cells into Th1 cells. Interestingly, we
found that IFNγ production in the cord blood of babies, in response to
Poly(I:C) transfection, was slightly increased when samples were
grouped according to BMI (Fig. 4C). Further analysis showed that IFNγ
also correlates positively with BMI (Fig. 4D)
4. Discussion
Most literature evaluating the effect of obesity on vaccine efficacy
has been carried out in adults. Obesity impacts negatively on vaccine
efficacy and has been shown to give rise to an inflamed phenotype,
including increased levels of circulating proinflammatory cytokines
[18]. Most vaccines are given to children in the first months & years of
life, when obesity of the child has not become a factor in vaccine effi-
cacy. However, studies have shown dysregulated immunity in obese
children of school going age, an age when important booster vaccina-
tions are given [21]. While trends in obesity continue to rise, women
tend to be more prone to obesity than men [22,23]. As the frequency of
obesity in young women increases, so too does the importance of our
understanding the effects of obesity on the offspring during and post-
pregnancy.
Maternal obesity as a factor in vaccine efficacy has not been re-
ported on to date. Given the fact that obesity is a risk factor for
decreased vaccine efficacy in adults, it is possible that maternal obesity
could affect early vaccine responses in their infants, as levels of circu-
lating cytokines are similar in mothers and their offspring, early in life
[24–28]. Importantly, maternal obesity has been linked to decreased
cord blood monocyte and dendritic cell responses to TLR activation,
including decreased TNFα production to LPS [14]. The importance of
being able to efficiently produce proinflammatory cytokines, such as
TNFα and Type I IFN, in response to infection or vaccination is well
recognised. Type I IFNs activate cellular immunity by activating DCs
and driving their maturation. This DC maturation allows antigen pre-
sentation to CD4+ T cells, cross-priming CD8+ T cells, and induction of
IFNγ and opsonizing antibodies [29,30]. Initiating Th1 responses and
cytotoxic T cells is a major target in vaccine development. Having
previously observed robust Th1 responses to cytosolic Poly(I:C) and
Poly(dA:dT) in cord blood samples, we were interested in evaluating
any impact of increased maternal BMI on these responses. Our initial
measurements of Type I IFN and TNFα found no correlation of in-
creasing maternal BMI on cytokine responses, or indeed increasing
childhood BMI on PBMC responses. We tested the potential of cytosolic
Poly(I:C) to promote this innate Th1 response and to encourage an
adaptive response through measuring the production of Th1-polarizing
IL-12p70 and induction of IFN-γ in CBMCs from healthy and over-
weight/obese women. Interestingly, we found a moderate positive













































Fig. 4. High Maternal BMI has a positive correlation with Poly(I:C)-induced Th1-polarising cytokines. CBMCs from babies born to healthy, overweight or obese
mothers were transfected with Poly(I:C) for 24 h and BioLegend LEGENDplex™ Human Inflammation Panels were used to measure the levels of (A and B) IL-12p70 or
(C and D) IFN-γ. (A and C) Graphs show mean ± SEM (n≥ 16). Two-way ANOVA with Bonferroni’s post-test (A) or Kruskal-Wallis non-parametric test with Dunn’s
post-test (C) was used to test for significant differences between treated cell groups. (B and D) Correlation analysis of Poly(I:C)-induced IL-12p70 production and
maternal BMI was carried out using Pearson’s correlation coefficient. Correlation analysis of Poly(I:C)-induced IFNγ production and maternal BMI was carried out
using Spearman’s rank correlation testing. *p < 0.05.
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neonates from overweight/obese mothers might be better able to in-
duce a cellular immune response to Poly(I:C). Similarly, IFNγ produc-
tion correlated positively, albeit weakly, with maternal BMI. While the
effect of maternal obesity on vaccine responses in neonates has not yet
been studied, a previous report has observed decreased CD4 T-cells in
neonates born to obese mothers along with reduced monocyte and
dendritic cell responses to TLR ligands [14]. The limited studies ex-
amining the effect of obesity on vaccination in children have focused on
Hepatitis B and influenza vaccines and have shown deficiencies in the
response to these vaccines in obese children. A recent paper from Wu, Y
et al. has shown that LPS-induced cytokine responses are decreased in
PBMCs from obese children compared to lean children [31]. This
blunted cytokine response to LPS is paralleled by the previously noted
study reporting that LPS-induced TNFα production is decreased in cord
blood monocytes and myeloid DCs of babies born to obese mothers
[14]. Given the use of LPS-derivatives such as MPLA in current adjuvant
development, this has implications for the obese population. With the
rise in obesity in general, and particularly childhood obesity, choice of
adjuvant for paediatric vaccines may gain importance to ensure the best
possible efficacy is attained in the breadth of stakeholder populations.
Collectively, our data highlights that neonates from obese mothers, and
importantly also obese children display functional cytokine responses
to the cytosolic nucleic acid Poly(I:C) demonstrating that activation of
CNA sensors may have potential in future vaccine development for this
at-risk population.
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